Press release
Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].What Is the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size and Projected Growth Rate?
There has been a significant increase in the market size of the pharmaceutical contract development and manufacturing organization (CMO) in the past few years. Expected to increase from $174.33 billion in 2024 to about $186.62 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. This considerable expansion during the historical period is due to robust economic growth in emerging markets, an escalation in healthcare spending, a surge in pharmaceutical research and development (R&D) expenditure and a growing tendency towards outsourcing.
The market size of the pharmaceutical contract development and manufacturing organization (CMO) is slated for robust expansion in the upcoming years. The market is projected to reach a size of $260.83 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. This surge during the forecast period is due to factors like surging government backing, expanded healthcare access, heightened investment, and advancements in biopharmaceutical development. Emerging trends over the forecast period include a heightened emphasis on sustainability, integrated application of artificial intelligence and digitization, the advent of resilient and innovative products, as well as increased investment and strategic alliances among market participants.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2825
What Are the Major Segments in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing organization (CMO) market covered in this report is segmented -
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
2) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
What Are The Driving Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Evolution?
The surge in the pharmaceutical contract development and manufacturing market can be attributed to the growing global demand for medicines. Given the widespread occurrence of diseases and the desire for extended longevity, there has been a heightened requirement for medications. This compels pharmaceutical firms to boost production of their existing pharmaceuticals and increase their research and development investment to stimulate the creation of new medications. To decrease operational expenses, these companies have begun to seek partnerships with contract manufacturing organizations (CMOs), thus stimulating the pharmaceutical contract development and manufacturing market. Alkermes PLC., a biopharmaceutical company, suggests that pharmaceutical contract manufacturing is likely to become a strategic choice for a wide range of companies, from large scale to niche specialty pharmaceutical entities, primarily driven by the pharmaceutical industry's quest for cost reduction.
Which Firms Dominate The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segments?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CMO) market include Lonza Group, Catalent Inc, WuXi AppTec Inc., Pfizer Inc, Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co., Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Boehringer Ingelheim International GmbH, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, AbbVie Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc, Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Johnson & Johnson, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
What Trends Are Driving Growth in The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Firms in the pharmaceutical contract development and manufacturing market are channeling their investments into acquisitions and partnerships with other players in the same market. This trend appears to be driven by the desire to broaden their worldwide market presence, fulfill client requirements, enhance their production abilities while keeping costs in check, and gain entry to cutting-edge technology and new services. This habit of engaging in mergers and acquisitions leads to a consolidation among contract service providers. For example, Pharma Nobis, a firm based in the U.S. that provides contract manufacturing and private label services, bought out Fagron's U.S. contract manufacturing operations in July 2022 for an undisclosed sum. This move is projected to enable Pharma Nobis to supply contract manufacturing and private label services to retailers and consumer healthcare firms in America. Fagron will retain a 20% ownership of the company.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-contract-developments-and-manufacturing-organization-cmo-global-market-report
Which Is The Largest Region In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2024. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
2. What is the CAGR expected in the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
3. What Are the Key Innovations Transforming the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Industry?
4. Which Region Is Leading the Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here
News-ID: 4005879 • Views: …
More Releases from The Business Research Company

Emerging Trends to Reshape the Xenotransplantation Market: Xvivo's Innovative Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Xenotransplantation Market Size By 2025?
The market size of xenotransplantation has seen robust expansion in the past few years. The market value is projected to increase from $14.68 billion in 2024 to $15.82 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.8%.…

Wood Based Panel Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Wood Based Panel Market Through 2025?
In recent times, the market size of wood-based panels has seen considerable growth. The market which was valued at $176.85 billion in 2024 is projected to rise to $190.52 billion in 2025, showing a compound annual…

Soaring Demand Set to Propel Wireless Speakers Market to $111.25 Billion by 2029
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Wireless Speakers Market Size Growth Forecast: What to Expect by 2025?
In recent times, the wireless speakers market has experienced substantial expansion. The market size is expected to increase from $37.14 billion in 2024 to $45.71 billion in 2025, growing at a compound annual growth rate (CAGR) of 23.1%.…

Wind Turbine Casting Market Landscape 2025: Forecast Data and Growth Strategy In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Wind Turbine Casting Industry Market Size Be by 2025?
The market size for wind turbine castings has seen solid growth in the past few years. Its value is projected to increase from $2.31 billion in 2024 to $2.46 billion in 2025, with a compound annual growth…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…